Project Oncology® - Programs - Prova Education

Episodes 1-16 of 19

- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
2
CME/CE
0.25 credits
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Ca...
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
1
CME/CE
0.25 credits
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Co...
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
7
CME/CE
0.25 credits
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
7
CME/CE
0.25 credits
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
7
CME/CE
0.25 credits
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits
- William J. Gradishar MD, FASCO, FACP
  Peer
- Peter Schmid, FRCP, MD, PhD
  Peer
6
CME/CE
0.25 credits
Perspectives for Clinical Practice: The Latest Advances for HER2-positive Met...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
4
CME/CE
0.25 credits
Keeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...
0.25 credits
- Mark A. Socinski, MD
  Peer
- Edward B. Garon, MD, MS
  Peer
3
CME/CE
0.25 credits
Keeping Pace: The Role of Immunotherapy After Disease Progression
0.25 credits
- Warner K. Huh, MD
  Peer
- Deborah K. Armstrong, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
11
CME/CE
0.25 credits
Keeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer
0.25 credits
- Mark A. Socinski, MD
  Peer
- Suresh S. Ramalingam, MD
  Peer
5
CME/CE
0.25 credits
Keeping Pace: The Role of Immunotherapy in the Frontline Setting
0.25 credits
- Peter H. O'Donnell, MD
  Peer
- Daniel P. Petrylak, MD
  Peer
12
CME/CE
0.25 credits
Keeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer
0.25 credits
- Mark A. Socinski, MD
  Peer
2
CME/CE
0.25 credits
Key Highlights from the Latest Clinical Trials in Lung Cancer
0.25 credits
- Paul Oberstein, MD
  Peer
- Eileen M. O'Reilly, MD
  Peer
2
CME/CE
0.25 credits
Gastrointestinal Cancer: Exploring the Latest Studies
0.25 credits
- Paul Oberstein, MD
  Peer
- Eileen M. O'Reilly, MD
  Peer
9
CME/CE
0.25 credits
Advancing Care in Gastrointestinal Cancers
0.25 credits
- Sara Hurvitz, MD
  Peer
- Tiffany Traina, MD
  Peer
9
CME/CE
0.25 credits
Advancements in Treatment Approaches for Triple-Negative Breast Cancer
0.25 credits
3
FDA Drug Information Updates
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

Prev
1
2
Next

1/2